Research Validation for Small & Mid Sized Life Science Companies

Home  Research Validation for Small & Mid Sized Life Science Companies

  • Share:
Name: Research Validation for Small & Mid Sized Life Science Companies
Date: November 1, 2017
Time: 5:00 PM - 7:00 PM EDT
Registration: Sorry, public registration for this event has been closed.
Event Description:

In an effort to help small and mid sized companies be able to access academia including medical training institution resources, cultivate entrepreneurial teams and help breakthrough ideas advance outside of the lab, the Council is organizing a conference which will allow these companies to access university leaders and others to share their concerns. 

Our goal is to have executives from these companies openly discuss their challenges and form a master list of match making opportunities between companies and universities/medical institutions.  This overview of the companies' needs and limitations could then be shared with students and physicians in training to have them incorporate these needs in their research efforts.

This will be an opportunity for the academic and medical communities to learn about regulations, resources, and hurdles in bringing new ideas to commercialization.  For the life sciences companies they will learn about what academia and medical institutions can and cannot do for them in the way of providing advisors, researchers and access to facilities.  For all concerned we hope this will prove to be a networking venue facilitating working partnerships among those of complimentary needs and interests. 

University Participants:
 Lauren Mangano Drenkard, Assistant Licensing Manager, Rutgers Office of Technology Commercialization
Peter Adam Galie, Assistant Professor, Biomedical Engineering, Rowan University

Sujatha KP, Research Project Manager, Penn State Hershey Medical Center
Kristen S. Labazzo, Executive Director, Medical Device Development Center, Department of Biomedical Engineering, Rutgers
Joe Montemarano, Princeton University
Vincent Smeraglia, Executive Director of Strategic Alliances, Rutgers Office of Technology Commercialization

Other Roundtable Participants:

Rao Bezwada, CEO, Bezwada Biomedical
I. Cem Girit, CEO, Biopticon Corporation
Bruce Boman, CEO, Cancer Genetics
Juby George-Vaze, CEO, Globex Health
Robert Jarmon, Healthy Functions
Mike Wiley, Vice President, NJ Health/Foundation VC Group, LLC

Event Media:
NJ Tech Council offices
98 Albany Street
New Brunswick, NJ 
Date/Time Information:
5 to 7 pm
Contact Information:
Paul Frank
NJ Tech Council members: $10.00
Future Members: $20.00
Set a Reminder:
Enter your email address below to receive a reminder message.

    [0] => Alissa Cadigan - RSM US
    [1] => Ashley Sarohkian - Capital One
    [2] => Badri Nittoor - eureQa
    [3] => Benjamin	Novak - Morgan Lewis
    [4] => Bin Guan - Yorktel
    [5] => Blake Goodman - JLL
    [6] => Bret Morgan - CoWerking
    [7] => Chris DeMayo - Withum
    [8] => Christina Giglio - Robert Half
    [9] => David Powell - Mission50
    [10] => George Abraham - Rhodium Strategies
    [11] => Hitesh Ramani - Deloitte
    [12] => Jennifer Core - BDO
    [13] => Joshua Goldberg - Nathlaw
    [14] => Kelly Ford - Edison Partners
    [15] => Kevin Askew - TechXtend
    [16] => Kevin Richards - Princeton Identity
    [17] => Marc McCabe - Crystal & Company
    [18] => Matt DeJesus - ViaWest
    [19] => Michael Crafton - Alvarez & Marsal
    [20] => Michael Dietze - TierPoint
    [21] => Michael Galkin - VoiceNext
    [22] => Michelle Capezza - Epstein Becker & Green
    [23] => Mike Funk - Alliant Tech
    [24] => Mike Profit - WorkWave
    [25] => Parag Pruthi - Niksun
    [26] => Phil Kennard - Futurestay
    [27] => Phil Romero - Grant Thornton
    [28] => Richard Cleaveland - Eisner Amper
    [29] => Ryan Sydorko - EY
    [30] => Scott Cowan - DLA Piper
    [31] => Tim Dluoik - KPMG
    [32] => Timur Pakay - FDU
    [33] => Vijay Ajuwalia - Edward Jones